NCT06314542 - Quantitative Evaluation of the Impact of Relaxing Eligibility Criteria for Lung Cancer Based on Real-world Data | Biotech Hunter

Enrollment

50,000

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions

Lung Cancer

Interventions

OTHER

relaxing eligibility criteria

Quantitative evaluation of the impact of relaxing eligibility criteria on the risk-benefit profile of drugs for lung cancer based on real-world data

Trial Locations (1)

RECRUITING

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing